Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | D(3) dopamine receptor | ||
Ligand | BDBM476861 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Binding Assay | ||
Ki | 0.200±n/a nM | ||
Citation | Tobinaga, H; Masuda, K; Inagaki, M; Yonehara, M; Masuda, M Nitrogen-containing condensed ring compounds having dopamine D3 antagonistic effect US Patent US10870660 Publication Date 12/22/2020 | ||
More Info.: | Get all data from this article, Assay Method | ||
D(3) dopamine receptor | |||
Name: | D(3) dopamine receptor | ||
Synonyms: | DOPAMINE D3 | DRD3 | DRD3_HUMAN | Dopamine D3 receptor | Dopamine D3 receptor (D3) | Dopamine D3 receptor (D3R) | Dopamine receptor | Dopamine receptor (D3) | Dopamine receptor D3 | ||
Type: | n/a | ||
Mol. Mass.: | 44243.43 | ||
Organism: | Homo sapiens (Human) | ||
Description: | n/a | ||
Residue: | 400 | ||
Sequence: |
| ||
BDBM476861 | |||
n/a | |||
Name | BDBM476861 | ||
Synonyms: | US10870660, Compound II-026 | ||
Type | Small organic molecule | ||
Emp. Form. | C26H33F2N5O2S | ||
Mol. Mass. | 517.634 | ||
SMILES | Cn1cc2c(cccc2n1)C(=O)N[C@H]1CC[C@H](CCN2CCc3nc(OCC(F)F)sc3CC2)CC1 |r,wU:16.18,wD:13.14,(12.57,-.99,;11.8,.35,;10.27,.51,;9.95,2.02,;8.61,2.79,;8.61,4.33,;9.95,5.1,;11.28,4.33,;11.28,2.79,;12.42,1.76,;7.28,2.02,;7.28,.48,;5.94,2.79,;4.61,2.02,;3.28,2.79,;1.94,2.02,;1.94,.48,;.61,-.29,;-.72,.48,;-2.06,-.29,;-3.26,.67,;-4.76,.32,;-5.43,-1.06,;-6.96,-1.27,;-7.23,-2.79,;-8.57,-3.56,;-9.9,-2.79,;-11.23,-3.56,;-12.57,-2.79,;-11.23,-5.1,;-5.88,-3.52,;-4.76,-2.45,;-3.26,-2.79,;-2.06,-1.83,;3.28,-.29,;4.61,.48,)| | ||
Structure |